Sébastien Gouy

ORCID: 0000-0001-5522-1925 · 5 papers in corpus
2022
·doi:10.1136/ijgc-2022-esgo.480
other 2022
Annals of surgical oncology ·doi:10.1245/s10434-022-11893-7

BACKGROUND: Endometrioid borderline ovarian tumor (EBOT) is a rare subtype of borderline ovarian malignancies. This study was designed to determine the prognosis of a series of EBOT. METHODS: This is a retrospective review of patients with…

other 2022
Journal of clinical medicine ·doi:10.3390/jcm11226765

Our aim was to assess the opinion of a panel of experts and obtain a consensus on the management of endometrial cancer in France and French Switzerland. A Delphi survey was carried out among a panel of French and French-speaking Swiss exper…

other 2021
Annals of surgical oncology ·doi:10.1245/s10434-021-10776-7

BACKGROUND: Clear cell borderline ovarian tumor (CCBOT) is one of the rarest subtypes of borderline ovarian malignancies. The aim of this study was to determine the prognosis of a series of CCBOT. PATIENTS AND METHODS: A retrospective revi…

other 2012
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1097/igc.0b013e3182534acf

BACKGROUND: The clear cell borderline ovarian tumor (CCBOT) of the ovary is a rare tumor accounting for less than 1% of BOT. Fewer than 25 cases have been reported in the literature (including details on clinical management and outcomes). T…